DG
FOMX

Delek Group’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Delek Group’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$145K Buy
62,437
+11,741
+23% +$35.1K 0.01% 213
2019
Q1 		$189K Buy
+50,696
New +$190K 0.01% 198

Other funds holding FOMX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Delek Group's FOMX Position: Q2 2019 in Review

Delek Group increased its Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) stake by 23% in Q2 2019, buying an estimated $35.1K and bringing the position to 62,437 shares worth $145K. The position accounts for 0.01% of the portfolio, ranked #213.

Delek Group first reported a position in FOMX in Q1 2019 and has held it in 2 quarters since. The position peaked at $189K in Q1 2019. 58 funds tracked by Wall St. Rank hold FOMX as of Q2 2019.

  • Delek Group held 62,437 shares of Foamix Pharmaceuticals Ltd. Ordinary Shares worth $145K as of Q2 2019.
  • Delek Group bought 11,741 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q2 2019, an estimated $35.1K.
  • Foamix Pharmaceuticals Ltd. Ordinary Shares made up 0.01% of Delek Group's portfolio in Q2 2019, its #213 holding.
  • Delek Group first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2019 and has held it in 2 quarters since.
  • Delek Group's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $189K in Q1 2019.
  • 58 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q2 2019.

Based on Delek Group's 13F filing for Q2 2019, filed 8 Aug 2019.